Skip to main content

ORIGINAL RESEARCH article

Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 15 - 2024 | doi: 10.3389/fgene.2024.1435622

Preimplantation genetic testing for Cockayne syndrome with a novel ERCC6 variant in a Chinese family

Provisionally accepted
Libin Mei Libin Mei *Xuemei He Xuemei He Yiyuan Zhang Yiyuan Zhang Xianjing Huang Xianjing Huang Pingping Qiu Pingping Qiu Hong Ji Hong Ji Lu Ding Lu Ding Yingying Shi Yingying Shi Yanru Huang Yanru Huang Ping Li Ping Li
  • Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China

The final, formatted version of the article will be published soon.

    Background: Cockayne syndrome (CS) is a rare, multisystem, autosomal recessive disorder characterized by cachectic dwarfism, nervous system abnormalities, and premature aging. Mutations in the ERCC6 and ERCC8 genes are the predominant causes of Cockayne syndrome, with ERCC6 gene mutations present in approximately 75% of cases. Methods: Trio-based whole-exome sequencing (trio-WES) was employed to identify potential pathogenic variants associated with CS.Preimplantation genetic testing for monogenic disorders (PGT-M) was conducted to prevent the transmission of the pathogenic variant. Results: Two compound heterozygous mutations were identified in ERCC6-c.1297G>T (p. Glu433*) and c.1607T>G (p. Leu536Trp)-with c.1297G>T representing a novel mutation. Four blastocysts resulting from intracytoplasmic sperm injection were subjected to biopsy. Genetic analyses revealed that E1 harbored maternal mutations in diploid embryos, E2 and E3 carried both paternal and maternal mutations in non-diploid embryos, and E4 did not carry paternal or maternal mutations in diploid embryos. Following the transfer of the E4 embryos, a single successful pregnancy was achieved. Conclusion: The successful application of PGT-M in this family offers a potential approach for addressing other monogenic diseases. The findings of this study broaden the variant spectrum of ERCC6 and will contribute to the molecular diagnosis and genetic counseling of CS. This case highlights the feasibility and effectiveness of PGT-M in preventing CS and provides valuable insights for similarly affected families.

    Keywords: Cockayne Syndrome, Whole-exome sequencing, ERCC6, preimplantation genetic testing for monogenic disorders (PGT-M), embryo

    Received: 20 May 2024; Accepted: 01 Oct 2024.

    Copyright: © 2024 Mei, He, Zhang, Huang, Qiu, Ji, Ding, Shi, Huang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Libin Mei, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.